High-Signal Health AI Consultancy
Identifying the Future of Clinical AI
We vet, architect, and scale the AI innovations that will define the next decade of public health.
Selection Excellence
In an era of AI saturation, we provide the technical scrutiny required to identify winners. We don't just implement AI; we validate its integrity and readiness for the most demanding environments.
Our expertise lies in separating signal from noise—finding the clinical AI innovations with genuine evidence, architectural rigor, and institutional-grade reliability.
We operate as a premium intelligence function: vetting, validating, and preparing elite AI technologies for institutional adoption at scale.
Our Services
Strategic Vetting
Technical due diligence for VCs and institutional buyers. We validate AI models for robustness, evidence-based performance, and institutional readiness.
Architectural Integrity
Building institutional-ready tech stacks that meet modern federal and clinical standards. We engineer for deployability, not just proof-of-concept.
Rapid Engagement Strategy
Designing the roadmap for innovators to work directly with large-scale public health entities. We accelerate adoption by eliminating friction.
FDA's FIRE Initiative
The FDA's FIRE (Foundational Innovation and Rapid Engagement) initiative represents a fundamental shift in how the agency evaluates and approves AI-driven healthcare solutions.
We help venture-backed innovators and enterprise teams prepare AI-Ready submissions that align with the FDA's goal of cutting out middlemen and enabling direct engagement with the regulatory body.
Our expertise: translating complex AI architectures into regulatory language, preparing technical dossiers that pass FDA review criteria, and positioning startups for expedited pathways.
The Innovation Gap
Powerful clinical AI systems already exist — yet many fail to reach real-world deployment because they are:
The result is extended pilots, regulatory delays, and a persistent gap between what is scientifically possible and what is clinically deployable.
Our Role: Innovation Accelerator
We operate as a neutral innovation accelerator and technical due diligence partner.
We connect:
Our mandate is to accelerate innovation adoption by eliminating regulatory friction, increasing technical clarity, and enabling defensible deployment.
Who We Work With
Healthcare Institutions & Regulators
Health systems, academic medical centers, and federal agencies operating under strict regulatory and compliance constraints that require defensible, clinically validated AI adoption.
Venture-Backed Clinical AI Teams
Founders building rigorous healthcare and regulatory infrastructure who value long-term credibility, technical rigor, FDA alignment, and real-world deployment over speed-to-market hype.
Clinical AI Must Respect Regulatory Reality
Healthcare AI succeeds when it is:
- •Clinically validated and evidence-driven
- •Built with FDA regulatory architecture from inception
- •Operationally grounded in healthcare workflows
- •Founder-respectful and investor-aligned
The future belongs to teams that can align clinical innovation with FDA strategy — not treat them as opposing forces. We help you get there.
Current Focus
We are actively building a vetted pipeline of clinical AI and regulatory technology companies aligned with emerging FDA initiatives and federal healthcare innovation programs focused on rapid, defensible deployment.
The Path From Innovation to Regulatory Approval
If you are building, funding, or responsible for adopting clinical AI in a regulated healthcare environment, we welcome rigorous, strategic conversations.